CCL2 and rheumatoid arthritis: Therefore, the ST6Gal1/Neu1 ratio is a potential predictor for remission or combined remission and low disease activity for DAS28-MCP-1 and SDAI assessment in rheumatoid arthritis, pending confirmation by other studies.